Logo image of KROS

KEROS THERAPEUTICS INC (KROS) Stock Earnings & Estimates

USA - Nasdaq - NASDAQ:KROS - US4923271013 - Common Stock

17.18 USD
-0.3 (-1.72%)
Last: 12/1/2025, 8:00:03 PM
17.18 USD
0 (0%)
After Hours: 12/1/2025, 8:00:03 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
KROS revenue by date.KROS revenue by date.

-100.00%
151K3.55M
2,250.99%
239.89M
6,657.46%
11.031M
-95.40%
13.73M
24.47%
62.921M
358.27%
100.85M
60.28%
120.47M
19.45%
221.31M
83.71%
288.94M
30.56%
EBITDA
YoY % growth
KROS ebitda by date.KROS ebitda by date.
-114.12M
-103.82%
-169.126M
-48.20%
-209.604M
-23.93%
9.731M
104.64%
-136.027M
-1,497.87%
-83.232M
38.81%
N/AN/AN/AN/AN/A
EBIT
YoY % growth
KROS ebit by date.KROS ebit by date.
-114.79M
-103.64%
-169.941M
-48.05%
-210.833M
-24.06%
13.665M
106.48%
-205.861M
-1,606.48%
-205.683M
0.09%
-169.58M
17.55%
-170.643M
-0.63%
-202.611M
-18.73%
-193.213M
4.64%
-201.731M
-4.41%
Operating Margin
KROS operating margin by date.KROS operating margin by date.
N/A-112,543.71%-5,938.96%5.70%-1,866.20%-1,498.06%-269.51%-169.20%-168.18%-87.30%-69.82%
EPS
YoY % growth
KROS eps by date.KROS eps by date.
-4.15
-64.68%
-5.20
-25.30%
-5.01
3.65%
0.91
118.16%
-4.48
-592.26%
-4.41
1.61%
-2.66
39.64%
-1.83
31.07%
-1.97
-7.45%
-0.11
94.18%
-0.04
66.67%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
-0.61
46.20%
-0.77
-121.34%
-0.79
-4.35%
-0.65
-261.25%
-1.14
-85.86%
-1.25
-62.38%
-1.26
-59.49%
-1.08
-66.27%
-0.97
14.99%
Revenue
Q2Q % growth
2.812M
-7.56%
502.86K
-99.76%
507.96K
-97.20%
513.06K
-96.40%

-100.00%
N/AN/AN/AN/A
EBITDA
Q2Q % growth
-51.755M
0.52%
N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-34.223M
35.74%
-41.095M
-127.03%
-41.541M
-4.33%
-43.524M
-182.92%
-51.094M
-49.30%
N/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-0.18
87.23%
-1.070.8983.15%
Q2 2025
Q2Q % growth
-0.76
39.20%
-1.150.3934.17%
Q1 2025
Q2Q % growth
3.62
399.17%
-0.253.871,560.50%
Q4 2024
Q2Q % growth
-1.14
14.93%
-1.00-0.14-13.69%
Q3 2024
Q2Q % growth
-1.41
-6.02%
-1.30-0.11-8.05%
Q2 2024
Q2Q % growth
-1.25
1.57%
-1.260.010.53%
Q1 2024
Q2Q % growth
-1.21
3.97%
-1.370.1611.93%
Q4 2023
Q2Q % growth
-1.34
-22.94%
-1.400.064.43%
Q3 2023
Q2Q % growth
-1.33
-44.57%
-1.370.043.25%
Q2 2023
Q2Q % growth
-1.27
-12.39%
-1.370.106.98%
Q1 2023
Q2Q % growth
-1.26
-24.75%
-1.15-0.11-10.01%
Q4 2022
Q2Q % growth
-1.09
-263.33%
-1.120.032.60%
Q3 2022
Q2Q % growth
-0.92
-5.75%
-1.260.3426.77%
Q2 2022
Q2Q % growth
-1.13
-68.66%
-1.08-0.05-4.71%
Q1 2022
Q2Q % growth
-1.01
-48.53%
-0.88-0.13-14.81%
Q4 2021
Q2Q % growth
-0.30
38.78%
-0.940.6467.94%
Q3 2021
Q2Q % growth
-0.87
-45.00%
-0.74-0.13-18.05%
Q2 2021
Q2Q % growth
-0.67
-8.06%
-0.670.00-0.28%
Q1 2021
Q2Q % growth
-0.68
86.69%
-0.59-0.09-14.94%
Q4 2020
Q2Q % growth
-0.49 -0.580.0915.72%
Q3 2020
Q2Q % growth
-0.60 -0.610.011.14%
Q2 2020
Q2Q % growth
-0.62 -0.690.079.95%
Q1 2020
Q2Q % growth
-5.11 -0.38-4.73-1,254.00%
KROS Yearly EPS VS EstimatesKROS Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 -2 -4 -6
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
14.262M
3,575.77%
3.876M10.386M267.96%
Q2 2025
Q2Q % growth
18.168M
49,002.70%
2.822M15.346M543.80%
Q1 2025
Q2Q % growth
211.246M
254,413.25%
2.227M209.019M9,385.68%
Q4 2024
Q2Q % growth
3.042M
2,027.27%
15.732M-12.69M-80.66%
Q2 2023
Q2Q % growth
165.75K-165.75K-100.00%
Q1 2023
Q2Q % growth
221.003K-221.003K-100.00%
Q4 2022
Q2Q % growth

-100.00%
874.283K-874.283K-100.00%
Q2 2022
Q2Q % growth

-100.00%
%
Q1 2022
Q2Q % growth
6.12M-6.12M-100.00%
Q4 2020
Q2Q % growth

-100.00%
%
Q3 2020
Q2Q % growth

-100.00%
63.75K-63.75K-100.00%
Q2 2020
Q2Q % growth

-100.00%
63.75K-63.75K-100.00%
Q1 2020
Q2Q % growth

-100.00%
84.997K-84.997K-100.00%
KROS Yearly Revenue VS EstimatesKROS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 50M 100M 150M 200M 250M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS40.88% 45.89% 0% 1978.36%
Revenue-3.6% 89.36% 0% 18.98%